Prosthetic Valve Sweing Ring Injection by Antiboitics Can Affect the Rate of Postoperative Infective Endocarditis?
- Conditions
- Prosthetic Valve Endocarditis
- Interventions
- Drug: Aminoglycoside
- Registration Number
- NCT05455788
- Lead Sponsor
- Assiut University
- Brief Summary
Follow-up of patients undergoing cardiac valve replacements with prosthetic valve after injection of sewing ring of prosthetic valve with aminoglycoside for prevention of infective endocarditis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
- patients who need cardiac valve replacement for rheumatic or degenerative causes
Exclusion Criteria
- Patients undergoing open heart surgery for any cause other than valve replacement
- patients who are younger than 20 years old.
- Patients undergoing valve repair.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients undergoing Cardiac valve replacement Aminoglycoside -
- Primary Outcome Measures
Name Time Method number of patients diagnosed with Infective endocarditis post valve replacement 6 months post operative percentage of post operative clinical and echocardiographic diagnosis of infective endocarditis on prosthetic valve
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie aminoglycoside's antimicrobial activity in prosthetic valve sewing rings to prevent infective endocarditis?
How does sewing ring aminoglycoside injection compare to systemic antibiotic prophylaxis in reducing postoperative infective endocarditis rates?
Which biomarkers predict susceptibility to prosthetic valve endocarditis recurrence after aminoglycoside-impregnated valve implantation?
What are the nephrotoxic and ototoxic risks of aminoglycoside sewing ring injection in NCT05455788 and their clinical management strategies?
Are fluoroquinolone or beta-lactam alternatives being evaluated for prosthetic valve endocarditis prevention alongside aminoglycoside injection in NCT05455788?
Trial Locations
- Locations (1)
Assiut University
🇪🇬Assiut, Egypt
Assiut University🇪🇬Assiut, EgyptKareem A HosnyContact01000401994kojakkemo@gmail.com